Final efficacy results of NCIC CTG IND.202: A randomized phase II study of recombinant interleukin-21 (rIL21) in patients with recurrent or metastatic melanoma (MM) Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Petrella, Teresa M
  • Mihalcioiu, Catalin Liviu Dragos
  • McWhirter, Elaine
  • Belanger, Karl
  • Savage, Kerry J
  • Song, Xinni
  • Hamid, Omid
  • Cheng, Tina
  • Davis, Mary L
  • Lee, Christopher W
  • Spatz, Alan
  • Monzon, Jose Gerard
  • Hagerman, Linda
  • Chen, Bingshu E
  • Dancey, Janet

publication date

  • May 20, 2013